Cite
MLA Citation
L. Leypoldt et al.. “P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL.” HemaSphere, vol. 6, n.d., pp. 816–817. http://access.bl.uk/ark:/81055/vdc_100159756131.0x000016